Home » All » Stock Forecast » Mineralys Therapeutics Inc. Common Stock Forecast

Mineralys Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
▼ -4.29%Market Cap $2.37B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$29.19 +1.41%Yesterday$28.61 -0.59%Tomorrow's Mineralys Therapeutics Inc. Common Stock (MLYS) setup is anchored to $28.78 and targets $29.19 (+1.41%). The near-term read is upside; watch $29.64 / $27.92 because daily realized volatility is about 7.29%.
Tomorrow's Mineralys Therapeutics Inc. Common Stock (MLYS) setup is anchored to $28.78 and targets $29.19 (+1.41%). The near-term read is upside; watch $29.64 / $27.92 because daily realized volatility is about 7.29%.
Week$30.05 +4.40%Last Week$28.25 -1.85%The 7-day Mineralys Therapeutics Inc. Common Stock model moves from $28.25 to $30.05 (+4.40%). It gives upside momentum context for this stock, so breaks around $29.64 / $27.92 matter more than a single tick.
The 7-day Mineralys Therapeutics Inc. Common Stock model moves from $28.25 to $30.05 (+4.40%). It gives upside momentum context for this stock, so breaks around $29.64 / $27.92 matter more than a single tick.
Month$31.48 +9.37%Last Month$27.65 -3.94%The 1-month Mineralys Therapeutics Inc. Common Stock target is $31.48 (+9.37%), compared with the live reference near $28.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Mineralys Therapeutics Inc. Common Stock target is $31.48 (+9.37%), compared with the live reference near $28.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$33.62 +16.82%Last Year$26.75 -7.07%The 1-year Mineralys Therapeutics Inc. Common Stock scenario points to $33.62 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Mineralys Therapeutics Inc. Common Stock scenario points to $33.62 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$38.65 +34.29%5 Years Ago$24.64 -14.40%The 5-year Mineralys Therapeutics Inc. Common Stock view is $38.65 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Mineralys Therapeutics Inc. Common Stock view is $38.65 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$29.19 +1.41%
Yesterday$28.61 -0.59%
Tomorrow's Mineralys Therapeutics Inc. Common Stock (MLYS) setup is anchored to $28.78 and targets $29.19 (+1.41%). The near-term read is upside; watch $29.64 / $27.92 because daily realized volatility is about 7.29%.
Week$30.05 +4.40%
Last Week$28.25 -1.85%
The 7-day Mineralys Therapeutics Inc. Common Stock model moves from $28.25 to $30.05 (+4.40%). It gives upside momentum context for this stock, so breaks around $29.64 / $27.92 matter more than a single tick.
Month$31.48 +9.37%
Last Month$27.65 -3.94%
The 1-month Mineralys Therapeutics Inc. Common Stock target is $31.48 (+9.37%), compared with the live reference near $28.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$33.62 +16.82%
Last Year$26.75 -7.07%
The 1-year Mineralys Therapeutics Inc. Common Stock scenario points to $33.62 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$38.65 +34.29%
5 Years Ago$24.64 -14.40%
The 5-year Mineralys Therapeutics Inc. Common Stock view is $38.65 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$30.66$29.89$29.13$28.37$27.611W AgoNow7D F

Technical Analysis

SellNeutralBuy
Neutral
1
Bullish
3
Neutral
1
Bearish

Key Indicators

IndicatorValueSignal
Price$28.78 Mid
Daily Change-4.29% Below
Volatility Cap20.0% Mid
Confidence66% Above
Data Sourcenasdaq-screener Mid

Historical Data

Current$28.78
Daily Change-4.29%
Market Cap$2.37B
Sourcenasdaq-screener
Current$28.78Daily Change-4.29%
Market Cap$2.37BSourcenasdaq-screener

Support & Resistance Levels

$27.92Support 1
$28.78Current
$29.64Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$28.78Live reference price
Used as the anchor for generated forecast calculations.
Next Month$31.48Model projection+9.37%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
66%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
66%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in MLYS today
Bullish Scenario
$30.22
+5.00% from current
Target Price$30.22
ScenarioUpside momentum
Probability58%
Base Scenario
$31.48
+9.37%
Target Price$31.48
ScenarioCapped drift
Probability66%
Bearish Scenario
$27.34
-5.00% from current
Target Price$27.34
ScenarioVolatility drawdown
Probability34%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 70/100
24H drift+1.41%
7D drift+4.40%
30D drift+9.37%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 67/100
1M outlook+9.37%
1Y outlook+16.82%
5Y outlook+34.29%

Frequently Asked Questions

Q What is the Mineralys Therapeutics Inc. Common Stock (MLYS) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Mineralys Therapeutics Inc. Common Stock is projected near $29.19 versus the current reference around $28.78. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for MLYS?
The weekly Mineralys Therapeutics Inc. Common Stock model points to $30.05, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Mineralys Therapeutics Inc. Common Stock 1-month and 1-year targets?
The Mineralys Therapeutics Inc. Common Stock 1-month target is $31.48 (+9.37%), while the 1-year target is $33.62 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Mineralys Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?
The Mineralys Therapeutics Inc. Common Stock long-horizon scenario sits near $38.65 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are MLYS support and resistance zones right now?
For Mineralys Therapeutics Inc. Common Stock, nearest resistance is around $27.92, while nearest support is around $29.64. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Mineralys Therapeutics Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
Mineralys Therapeutics Inc. Common Stock Forecast 2026 – Tomorrow, Week & Month